Ibrutinib versus placebo in patients with asymptomatic, treatment-naive early stage chronic lymphocytic leukemia (CLL): primary endpoint results of the phase 3 double-blind randomized CLL12 trial

著录项

• 来源
  《Leukemia and lymphoma》 |2020年第s1期|共3页
• 作者

  Langerbeins Petra; Bahlo Jasmin; Rhein Christina; Gerwin Henrik; Cramer Paula; Fuerstenau Moritz; Al-Sawaf Othman; von Tresckow Julia; Fink Anna-Maria; Kreuzer Karl-Anton; Vehling-Kaiser Ursula; Tausch Eugen; Mueller Lothar; Eckart Michael J.; Schlag Rudolf; Freier Werner; Gaska Tobias; Balser Christina; Wendtner Clemens Martin; Reiser Marcel; Stauch Martina; Fischer Kirsten; Stilgenbauer Stephan; Eichhorst Barbara; Hallek Michael;

  展开▼
• 作者单位

  Univ Hosp Cologne Cologne Germany;

  Univ Hosp Cologne Cologne Germany;

  Univ Hosp Cologne Cologne Germany;

  Univ Cologne Cologne Germany;

  Univ Cologne Fac Med Cologne Germany;

  Univ Cologne Cologne Germany;

  Univ Hosp Cologne Cologne Germany;

  Univ Cologne Cologne Germany;

  Univ Hosp Cologne Cologne Germany;

  Univ Cologne Cologne Germany;

  Tagesklin Landshut Landshut Germany;

  Univ Ulm Ulm Germany;

  Oncol Practice Leer Leer Germany;

  Onkol Gemeinschaftspraxis Wurzburg Germany;

  Medicinum Hildesheim Hildesheim Germany;

  Bruderkrankenhaus St Josef Paderborn Paderborn Germany;

  Univ Munich Munich Clin Schwabing Acad Teaching Hosp Munich Germany;

  Univ Hosp Cologne German CLL Study Grp Cologne Germany;

  Univ Ulm Ulm Germany;

  Univ Hosp Cologne Cologne Germany;

  Univ Cologne Cologne Germany;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词